Why injection site doesn't matter for TB-500 (unlike BPC-157): TB-500 circulates through the bloodstream and migrates to areas of tissue damage - it seeks out injured tissue via actin upregulation signals
The notable peptide vaccines that have undergone phase I/II/III clinical trials include HER-2/neu immunodominant peptide (lung, breast, or ovarian cancer) [6971], Mucin-1 (MUC-1, Stimuvax), peptide (breast or colon cancer) [72, 73], Carcinoembryonic antigen (colorectal, gastric, breast, pancreatic and non-small-cell lung cancers) [74, 75], Prostate-specific membrane antigen (prostate cancer) [7678], HPV-16 E7 peptide (cervical cancer) [79], Ras oncoprotein peptide (colorectal and pancreatic carcinomas) [8082], and Melanoma antigens (Melanoma) [62, 68, 8385]
2026 guide
Summary Keywords HGF, MET, synaptogenesis, autism, cerebral ischemia, spinal cord injury, amyotrophic lateral sclerosis, multiple sclerosis Citation Desole C, Gallo S, Vitacolonna A, Montarolo F, Bertolotto A, Vivien D, Comoglio P and Crepaldi T (2021) HGF and MET: From Brain Development to Neurological Disorders
